Blanchette P - Search Results

1

Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis.

Raphael J, Vincent M, Boldt G, Shah PS, Rodrigues G, Blanchette P. Raphael J, et al. Among authors: blanchette p. Am J Clin Oncol. 2019 May;42(5):440-445. doi: 10.1097/COC.0000000000000533. Am J Clin Oncol. 2019. PMID: 30913091

2

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

Dhesy-Thind S, Fletcher GG, Blanchette PS, Clemons MJ, Dillmon MS, Frank ES, Gandhi S, Gupta R, Mates M, Moy B, Vandenberg T, Van Poznak CH. Dhesy-Thind S, et al. J Clin Oncol. 2017 Jun 20;35(18):2062-2081. doi: 10.1200/JCO.2016.70.7257. Epub 2017 Mar 6. J Clin Oncol. 2017. PMID: 28618241 Review.

3

Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.

Blanchette PS, Desautels DN, Pond GR, Bartlett JMS, Nofech-Mozes S, Yaffe MJ, Pritchard KI. Blanchette PS, et al. Breast Cancer Res Treat. 2018 Jul;170(1):169-177. doi: 10.1007/s10549-018-4734-x. Epub 2018 Mar 8. Breast Cancer Res Treat. 2018. PMID: 29520532

4

Bone-Targeted Therapy in Early Breast Cancer.

Jerzak KJ, Raphael J, Desautels DN, Blanchette PS, Tyono I, Pritchard KI. Jerzak KJ, et al. Oncology (Williston Park). 2018 Nov 15;32(11):562-9. Oncology (Williston Park). 2018. PMID: 30474104 Free article. Review.

5

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.

Hannouf MB, Zaric GS, Blanchette P, Brezden-Masley C, Paulden M, McCabe C, Raphael J, Brackstone M. Hannouf MB, et al. Among authors: blanchette p. Pharmacogenomics J. 2020 Feb;20(1):27-46. doi: 10.1038/s41397-019-0089-x. Epub 2019 May 27. Pharmacogenomics J. 2020. PMID: 31130722

6

Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada.

Blanchette PS, Chung H, Pritchard KI, Earle CC, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor A, Smieja M, Zahariadis G, Campigotto A, Kwong JC. Blanchette PS, et al. J Clin Oncol. 2019 Oct 20;37(30):2795-2804. doi: 10.1200/JCO.19.00354. Epub 2019 Aug 29. J Clin Oncol. 2019. PMID: 31465264

7

Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.

Blanchette PS, Lam M, Richard L, Allen B, Shariff SZ, Vandenberg T, Pritchard KI, Chan KKW, Louie AV, Desautels D, Raphael J, Earle CC. Blanchette PS, et al. Breast Cancer Res Treat. 2020 Jan;179(1):217-227. doi: 10.1007/s10549-019-05430-6. Epub 2019 Oct 1. Breast Cancer Res Treat. 2020. PMID: 31571072

8

Predictors of Survival Benefit From Immune Checkpoint Inhibitors in Patients With Advanced Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis.

Raphael J, Batra A, Boldt G, Shah PS, Blanchette P, Rodrigues G, Vincent MD. Raphael J, et al. Among authors: blanchette p. Clin Lung Cancer. 2020 Mar;21(2):106-113.e5. doi: 10.1016/j.cllc.2019.11.004. Epub 2020 Jan 3. Clin Lung Cancer. 2020. PMID: 31992521

9

Efficacy and safety of ALK inhibitors in ALK-rearranged non-small cell lung cancer: A systematic review and meta-analysis.

Breadner D, Blanchette P, Shanmuganathan S, Boldt RG, Raphael J. Breadner D, et al. Among authors: blanchette p. Lung Cancer. 2020 Jun;144:57-63. doi: 10.1016/j.lungcan.2020.04.011. Epub 2020 Apr 19. Lung Cancer. 2020. PMID: 32371261

10

The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.

Blanchette PS, Lam M, Le B, Richard L, Shariff SZ, Pritchard KI, Raphael J, Vandenberg T, Fernandes R, Desautels D, Chan KKW, Earle CC. Blanchette PS, et al. J Geriatr Oncol. 2020 Sep;11(7):1132-1137. doi: 10.1016/j.jgo.2020.05.009. Epub 2020 Jun 29. J Geriatr Oncol. 2020. PMID: 32611495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters